MXPA04005554A - Benzotiazoles. - Google Patents
Benzotiazoles.Info
- Publication number
- MXPA04005554A MXPA04005554A MXPA04005554A MXPA04005554A MXPA04005554A MX PA04005554 A MXPA04005554 A MX PA04005554A MX PA04005554 A MXPA04005554 A MX PA04005554A MX PA04005554 A MXPA04005554 A MX PA04005554A MX PA04005554 A MXPA04005554 A MX PA04005554A
- Authority
- MX
- Mexico
- Prior art keywords
- lower alkyl
- optionally substituted
- pyran
- dihydro
- compounds
- Prior art date
Links
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical class C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- -1 3,6-dihydro-2H-pyran-4-yl Chemical group 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 3
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 125000002757 morpholinyl group Chemical group 0.000 abstract 2
- 108050000203 Adenosine receptors Proteins 0.000 abstract 1
- 102000009346 Adenosine receptors Human genes 0.000 abstract 1
- 101150051188 Adora2a gene Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/84—Naphthothiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
La presente invencion se refiere a compuestos de formula general (I), en la que R1 es el 3,6-dihidro-2H-piran-4-ilo, el 5,6-dihidro-4H-piran-3-ilo, el 5,6-dihidro-4H-piran-2-ilo, el tetrahidropiran-2-, -3- o -4-ilo, el ciclohex-2-enilo, el ciclohexilo o es el 1,2,3,6, tetrahidropiridi-4-ilo o piperidin-4-ilo, que estan opcionalmente sustituidos por C(O)CH3 en la posicion 2 del atomo de hidroxi o es fenil, opcionalmente sustituido por N; R2 es alquilo de bajo peso molecular, piperidin-1-ilo opcionalmente sustituido por -(CH2)n-N(R`)-C(O)- -(CH2)n-NR2`, -(CH2)n -o-alquilo de bajo peso molecular; o es morfolinilo o es piridinilo que esta opcionalmente sustituido por halogeno, -N(R`)- -(CH2)n-O-alquilo de bajo peso molecular, morfolinilo opcionalmente sustituido por halogeno. -NR1) -(CH2)n-O- alquilo inferior, alquilo inferior, alcoxi inferior, morofolinilo o -(CH2)n- pirrolidinilo; n es el numero 0, 1 o 2; R` es hidrogeno o alquilo de bajo peso molecular, y a sales de adicion de acido farmaceuticamente aceptables de los mismos. se ha constatado que los compuestos de la formula general I son ligandos del receptor de adenosina. De modo especifico, los compuestos de la presente invencion tienen buena afinidad con el receptor A2A y pueden utilizarse para el tratamiento de enfermedades relacionadas con este receptor.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01129273 | 2001-12-12 | ||
| PCT/EP2002/013769 WO2003053961A1 (en) | 2001-12-12 | 2002-12-05 | Benzothiazoles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA04005554A true MXPA04005554A (es) | 2004-09-10 |
Family
ID=8179487
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA04005554A MXPA04005554A (es) | 2001-12-12 | 2002-12-05 | Benzotiazoles. |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6734179B2 (es) |
| EP (1) | EP1456202B1 (es) |
| JP (1) | JP4283116B2 (es) |
| KR (1) | KR100582696B1 (es) |
| CN (1) | CN1286834C (es) |
| AR (1) | AR037792A1 (es) |
| AT (1) | ATE309242T1 (es) |
| AU (1) | AU2002356628B2 (es) |
| BR (1) | BR0214837A (es) |
| CA (1) | CA2469876C (es) |
| DE (1) | DE60207294T2 (es) |
| ES (1) | ES2251628T3 (es) |
| GT (1) | GT200200270A (es) |
| MX (1) | MXPA04005554A (es) |
| PA (1) | PA8561101A1 (es) |
| PE (1) | PE20030751A1 (es) |
| PL (1) | PL371064A1 (es) |
| RU (1) | RU2293736C2 (es) |
| TW (1) | TW200409772A (es) |
| UY (1) | UY27578A1 (es) |
| WO (1) | WO2003053961A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2301962T3 (es) * | 2003-01-13 | 2008-07-01 | F. Hoffmann-La Roche Ag | Derivados de benzoxazol y su uso como ligandos de receptor de adenosina. |
| US6872833B2 (en) | 2003-04-14 | 2005-03-29 | Hoffmann-La Roche Inc. | Adenosine receptor ligands |
| EP1636223B1 (en) * | 2003-05-19 | 2008-03-19 | F. Hoffman-la Roche AG | Benzothiazole derivatives as adenosine receptor ligands |
| AU2004241720B2 (en) * | 2003-05-21 | 2008-11-06 | F. Hoffmann-La Roche Ag | Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine A2A receptor |
| KR20060058132A (ko) | 2003-09-19 | 2006-05-29 | 에프. 호프만-라 로슈 아게 | 아데노신 수용체 리간드로서의 싸이아졸로피리딘 유도체 |
| TWI370820B (en) | 2005-04-27 | 2012-08-21 | Takeda Pharmaceutical | Fused heterocyclic compounds |
| WO2008052930A2 (en) * | 2006-11-03 | 2008-05-08 | F. Hoffmann-La Roche Ag | Preparation of 4-alk0xy-7- (tetrahydropyran-4-yl) benzothiazol-2-amine derivatives |
| DE102011005232A1 (de) | 2011-03-08 | 2012-09-13 | AristoCon GmbH & Co. KG | Adenosin und seine Derivate zur Verwendung in der Schmerztherapie |
| AR117844A1 (es) * | 2019-01-22 | 2021-09-01 | Merck Patent Gmbh | Derivados de tiazolopiridina como antagonistas del receptor de adenosina |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3374550D1 (en) | 1982-12-21 | 1987-12-23 | Johnsen Jorgensen Plastics Ltd | Dispensing container |
| RU2041216C1 (ru) * | 1991-04-04 | 1995-08-09 | Эйсай Ко., Лтд. | Производное бензотиазола или его фармакологически приемлемая соль |
| DE69833224T2 (de) | 1997-11-10 | 2006-09-28 | Bristol-Myers Squibb Co. | Benzothiazole als protein tyrosin-kinase inhibitoren |
| CA2344828A1 (en) | 1998-09-22 | 2000-03-30 | Tomoyuki Kanda | ¬1,2,4|triazolo¬1,5-c|pyrimidine derivatives |
| YU96502A (sh) * | 2000-06-21 | 2006-01-16 | F. Hoffmann-La Roche Ag. | Derivati benzotiazola |
| US6620811B2 (en) * | 2001-11-19 | 2003-09-16 | Hoffmann-La Roche Inc. | Isonicotin- and nicotinamide derivatives of benzothiazoles |
| US6713499B2 (en) * | 2001-12-12 | 2004-03-30 | Hoffman-La Roche Inc. | 7-Amino-benzothiazole derivatives |
-
2002
- 2002-12-02 US US10/307,698 patent/US6734179B2/en not_active Expired - Fee Related
- 2002-12-05 PL PL02371064A patent/PL371064A1/xx not_active Application Discontinuation
- 2002-12-05 EP EP02805304A patent/EP1456202B1/en not_active Expired - Lifetime
- 2002-12-05 CA CA2469876A patent/CA2469876C/en not_active Expired - Fee Related
- 2002-12-05 RU RU2004121683/04A patent/RU2293736C2/ru not_active IP Right Cessation
- 2002-12-05 KR KR1020047008941A patent/KR100582696B1/ko not_active Expired - Fee Related
- 2002-12-05 CN CNB028248481A patent/CN1286834C/zh not_active Expired - Fee Related
- 2002-12-05 MX MXPA04005554A patent/MXPA04005554A/es active IP Right Grant
- 2002-12-05 AU AU2002356628A patent/AU2002356628B2/en not_active Ceased
- 2002-12-05 BR BR0214837-4A patent/BR0214837A/pt not_active Application Discontinuation
- 2002-12-05 ES ES02805304T patent/ES2251628T3/es not_active Expired - Lifetime
- 2002-12-05 WO PCT/EP2002/013769 patent/WO2003053961A1/en not_active Ceased
- 2002-12-05 DE DE60207294T patent/DE60207294T2/de not_active Expired - Lifetime
- 2002-12-05 JP JP2003554677A patent/JP4283116B2/ja not_active Expired - Fee Related
- 2002-12-05 AT AT02805304T patent/ATE309242T1/de active
- 2002-12-09 TW TW091135553A patent/TW200409772A/zh unknown
- 2002-12-10 PE PE2002001189A patent/PE20030751A1/es not_active Application Discontinuation
- 2002-12-10 PA PA20028561101A patent/PA8561101A1/es unknown
- 2002-12-11 GT GT200200270A patent/GT200200270A/es unknown
- 2002-12-11 AR ARP020104800A patent/AR037792A1/es unknown
- 2002-12-11 UY UY27578A patent/UY27578A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PA8561101A1 (es) | 2003-07-28 |
| AU2002356628B2 (en) | 2008-04-17 |
| EP1456202B1 (en) | 2005-11-09 |
| KR100582696B1 (ko) | 2006-05-23 |
| RU2004121683A (ru) | 2006-01-10 |
| TW200409772A (en) | 2004-06-16 |
| DE60207294T2 (de) | 2006-07-20 |
| PL371064A1 (en) | 2005-06-13 |
| ATE309242T1 (de) | 2005-11-15 |
| ES2251628T3 (es) | 2006-05-01 |
| JP4283116B2 (ja) | 2009-06-24 |
| BR0214837A (pt) | 2004-08-31 |
| EP1456202A1 (en) | 2004-09-15 |
| AR037792A1 (es) | 2004-12-01 |
| GT200200270A (es) | 2003-07-30 |
| WO2003053961A1 (en) | 2003-07-03 |
| PE20030751A1 (es) | 2003-09-05 |
| DE60207294D1 (en) | 2005-12-15 |
| US6734179B2 (en) | 2004-05-11 |
| CA2469876A1 (en) | 2003-07-03 |
| UY27578A1 (es) | 2003-06-30 |
| CN1286834C (zh) | 2006-11-29 |
| RU2293736C2 (ru) | 2007-02-20 |
| CA2469876C (en) | 2011-01-11 |
| AU2002356628A1 (en) | 2003-07-09 |
| KR20040073473A (ko) | 2004-08-19 |
| CN1602310A (zh) | 2005-03-30 |
| JP2005521647A (ja) | 2005-07-21 |
| US20030144288A1 (en) | 2003-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200407134A (en) | Nicotin-or isonicotin benzothiazole derivatives | |
| ATE540928T1 (de) | Isochinolinverbindungen und ihre medizinische verwendung | |
| TW200740760A (en) | Malonamide derivatives | |
| TW200728305A (en) | Spiropiperidine beta-sectetase inhibitors for the treatment of alzheimer's disease | |
| SE0104332D0 (sv) | Therapeutic agents | |
| MX2009002229A (es) | Benzotriazoles como moduladores de cinasas. | |
| EP1423111A4 (en) | FXR NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS | |
| WO2006044497A3 (en) | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer’s disease | |
| JO2262B1 (en) | Benzodiazepine derivatives | |
| DE60236600D1 (de) | Substituierte 1h-dihydropyrazole, ihre herstellung und verwendung | |
| NZ533310A (en) | Benzimidazoles useful as protein kinase inhibitors | |
| TW200505903A (en) | CGRP receptor antagonists | |
| ATE437872T1 (de) | Proteinkinaseinhibitoren | |
| NO20054404L (no) | 5,7-Diaminopyrazolo [4,3-D] Pyrimidiner Anvendelige ved behandling av of Hypertensjon | |
| MX2007000505A (es) | Derivados de oxindol sustituidos y medicamentos que contienen los mismos. | |
| MXPA00006605A (es) | Compuestos de carbonil-indol biciclicos como agentes antiinflamatorios/analgesicos. | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| DE60309057D1 (de) | Azabicycloderivate als antagonisten des muscarinischen rezeptors | |
| ATE357453T1 (de) | Comt-inhibitoren | |
| MXPA04005554A (es) | Benzotiazoles. | |
| BRPI0518231A2 (pt) | derivados de 2-amido-4-feniltiazol, o respectivo preparo e a respectiva aplicaÇço em terapÊutica | |
| TW200716547A (en) | Piperidin-4-yl-amide derivatives | |
| ATE476431T1 (de) | Piperidin- und azetidinderivate als glyt1- inhibitoren | |
| DK1256581T3 (da) | Forebyggende eller terapeutiske midler til gastrisk eller ösofageal regurgitation | |
| DE60330864D1 (de) | Neue verbindungen, deren verwendung und herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |